C-Met signalling in an HGF/SF-insensitive variant MDCK cell line with constitutive motile/invasive behaviour

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Webb, C. P.
	Articles by Warn, R. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Webb, C. P.
	Articles by Warn, R. M.

Bardelli, A., Maina, F., Gout, I., Fry, M. J., Waterfield, M. D., Comoglio, P. M. and Ponzetto, C (1992). Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains. Oncogene 7, 1973-1978.[Medline]

Behrens, J., Mareel, M. M., Van Roy, F. M. and Birchmeier, W (1989). Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol 108, 2345-2447.

Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kniecik, T. E., Vande Woude, G. F. and Aaronson, S. A (1991). Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804.[Abstract/Free Full Text]

Cochet, C., Gill, G. N., Meisenhelder, J., Cooper, J. A. and Hunter, T (1984). C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem 259, 2553-2558.[Abstract/Free Full Text]

Cooper, S. C., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M. and Vande Woude, G. F (1984). Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311, 29-33.[Medline]

Crepaldi, T., Prat, M., Giordano, S., Medico, E. and Comoglio, P. M (1994). Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum. J. Biol. Chem 269, 1750-1755.[Abstract/Free Full Text]

Dowrick, P. G., Prescott, A. R. and Warn, R. M (1991). Scatter factor effects major changes in the cytoskeletal organisation of epithelial cells. Cytokine 3, 299-310.[Medline]

Faletto, D. L., Kaplan, D. R., Halverson, D. O., Rosen, E. R. and Vande Woude, G. F (1993). Signal transduction in c-met mediated motogenesis. EXS 65, 107-130.[Medline]

Friedman, B., Van Amsterdam, J., Fujiki, H. and Rosner, M. R (1989). Phosphorylation at threonine-654 is not required for negative regulation ofthe epidermal growth factor receptor by non-phorbol tumor promoters. Proc. Nat. Acad. Sci. USA 86, 812-816.[Abstract/Free Full Text]

Fukazawa, H., Li, P. M., Yamamoto, C., Murakami, Y., Miizuno, S. and Uehara, Y. ( (1991). Specific inhibition of cytoplasmic tyrosine kinases by herbimycin A in vitro. Biochem. Pharmacol 42, 1661-1671.[Medline]

Gandino, L., Di Renzo, M. F., Giordano, S., Bussolino, F. and Comoglio, P. M (1990). Protein kinase-C activation inhibits the tyrosine phosphorylation of the c-met protein. Oncogene 5, 721-725.[Medline]

Gandino, L., Munaron, L., Naldini, L., Ferracini, R., Magni, M. and Comoglio, P. M (1991). Intracellular calcium regulates the tyrosine kinase receptor encoded by the met oncogene. J. Biol. Chem 266, 16098-16104.[Abstract/Free Full Text]

Gandino, L., Longati, P., Medico, E., Prat, M. and Comoglio, P. M (1994). Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor kinase. J. Biol. Chem 269, 1815-1820.[Abstract/Free Full Text]

Gherardi, E. and Stoker, M (1991). Hepatocyte growth factor- scatter factor: mitogen, motogen, and met. Cancer Cells 3, 227-232.[Medline]

Giordano, S., Di Renzo, M. F., Narsimhan, R., Cooper, C. S., Rosa, C. and Comoglio, P. M (1989). Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4, 1383-1388.[Medline]

Giordano, S., Ponzetto, C., Di Renzo, M. F., Cooper, C. S. and Comoglio, P. M (1989). Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339, 155-156.[Medline]

Gonzatti-Haces, M., Seth, A., Park, M., Copeland, T., Oroszlan, S. and Vande Woude, G. F (1988). Characterisation of the TPR-MET oncogene p65 and the MET proto-oncogene p140 protein tyrosine kinases. Proc. Nat. Acad. Sci. USA 85, 21-25.[Abstract/Free Full Text]

Iyer, A., Kmiecik, T., Park, M., Dear, I., Blair, P., Dunn, K. J., Sutrave, P., Ihle, J., Bodescot, M. and Vande Woude, G. F (1990). Structure, tissue-specific expression, and transforming activity of the mouse met proto-oncogene. Cell Growth Differ 1, 87-95.[Abstract]

Lee, C. C. and Yamada, K. M (1994). Identification of a novel type of alternative splicing of a tyrosine kinase receptor. Juxtamembrane deletion of the c-met protein kinase C serine phosphorylation regulatory site. J. Biol. Chem 269, 19457-19461.[Abstract/Free Full Text]

Lee, C. C. and Yamada, K. M (1995). Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte growth factor receptor. J. Biol. Chem 270, 507-510.[Abstract/Free Full Text]

Longati, P., Bardelli, A., Ponzetto, C., Naldini, L. and Comoglio, P. M (1994). Tyrosines 1234-1235are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9, 49-57.[Medline]

Madin, S. H. and Darby, N. B (1958). Established kidney cell lines of normal adult bovine and ovine origin. Proc. Soc. Exp. Biol. Med 98, 574-576.

Mondino, A., Giordano, S. and Comoglio, P. M (1991). Defective post-translational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor). Mol. Cell Biol 11, 6084-6092.[Abstract/Free Full Text]

Montesano, R., Matsumoto, K., Nakamura, T. and Orci, L (1991). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908.[Medline]

Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R., Michalopoulos, G. K., Birchmeier, W. and Comoglio, P. M (1991). Scatter factor and hepatocyte growth factor are indistinguishable ligands for the met receptor. EMBO J 10, 2867-2878.[Medline]

Naldini, L., Vigna, E., Natshimhan, R., Gaudino, G., Zarnegar, R., Michalopoulos, G. K. and Comoglio, P. M (1991). Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor proto-oncogene c-met. Oncogene 6, 501-504.[Medline]

Naldini, L., Vigna, E., Ferracini, R., Longati, P., Gandino, L., Prat, M. and Comoglio, P. M (1991). The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation. Mol. Cell. Biol 11, 1793-1803.[Abstract/Free Full Text]

Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G. and Vande Woude, G. F (1986). Mechanisms of met oncogene activation. Cell 45, 895-904.[Medline]

Park, M., Dean, M., Kaul, K., Braun, M. J., Gonda, M. A. and Vande Woude, G. F. ( (1987). Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Nat. Acad. Sci. USA 84, 6379-6383.[Abstract/Free Full Text]

Pelicci, G., Giordano, S., Zhen, Z., Salcini, A. E., Lanfrancone, L., Bardelli, A., Panayotou, G., Waterfield, M. D., Ponzetto, C., Pelicci, P. G., et al. ( (1995). The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene 10, 1631-1638.[Medline]

Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., Zonca, P., Giordano, S., Graziani, A., Panayoyou, G. and Comoglio, P. M (1994). A multifunctional docking site mediates signalling and transformation by the HGF/SF receptor family. Cell 77, 261-271.[Medline]

Prat, M., Crepaldi, T., Gandino, L., Giordano, S., Longati, P. and Comoglio, P. M (1991). C-terminal truncated forms of met, the hepatocyte growth factor receptor. Mol. Cell Biol 11, 5954-5962.[Abstract/Free Full Text]

Rong, S., Bodescot, M., Blair, D., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S. and Vande Woude, G. F (1992). Tumorgenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol 12, 5152-5158.[Abstract/Free Full Text]

Rosen, E. M., Nigam, S. K. and Goldberg, I. D (1994). Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J. Cell Biol 127, 1783-1787.[Abstract/Free Full Text]

Sonnenberg, E., Meyer, D., Weidner, K. M. and Birchmeier, W (1993). Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol 123, 223-235.[Abstract/Free Full Text]

Stoker, M., Gherardi, E., Perryman, M. and Gray, J (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327, 238-242.

Tempest, P. R., Stratton, M. R. and Cooper, C. S (1988). Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br. J. Cancer 58, 3-7.[Medline]

Tsarfaty, I., Resau, J. H., Rulong, S., Keydar, I., Faletto, D. and Vande Woude, G. F (1992). The met proto-oncogene receptor and lumen formation. Science 257, 1258-1261.[Abstract/Free Full Text]

Uehara, Y., Murakami, Y., Mizuno, S. and Kawai, S (1988). Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A. Virology 164, 294-298.[Medline]

van der Geer, P., Hunter, T. and Lindberg, R. A (1994). Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol 10, 251-337.

Villa Moruzzi, E., Lapi, S., Prat, M., Gaudino, G. and Comoglio, P. M (1993). A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor. J. Biol. Chem 268, 18176-18180.[Abstract/Free Full Text]

Warn, R (1994). A scattering of factors. Curr. Biol 4, 1043-1045.[Medline]

Warn, R (1995). A scattered Jigsaw. Nature 376, 723-.[Medline]

Weidner, K. M., Behrens, J., Vandekerckhove, J. and Birchmeier, W (1990). Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol 111, 2097-2108.[Abstract/Free Full Text]

Weidner, K. M., Sachs, M., Riethmacher, D. and Birchmeier, W (1995). Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc. Nat. Acad. Sci. USA 92, 2597-2601.[Abstract/Free Full Text]

Zhen, Z., Giordano, S., Longati, P., Medico, E., Campiglio, M. and Comoglio, P. M (1994). Structural and functional domains critical for constitutive activation of the HGF-receptor (Met). Oncogene 9, 1691-1697.[Medline]

This article has been cited by other articles:

B. Dekel, S. Biton, G. M. Yerushalmi, R. T. Altstock, L. Mittelman, D. Faletto, N. I. Smordinski, and I. Tsarfaty
In situ activation pattern of Met docking site following renal injury and hypertrophy
Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1493 - 1504.
[Abstract] [Full Text] [PDF]

B. Dekel, S. Biton, G. M. Yerushalmi, R. T. Altstock, L. Mittelman, D. Faletto, N. I. Smordinski, and I. Tsarfaty
In situ activation pattern of Met docking site following renal injury and hypertrophy
Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1493 - 1504.
[Abstract] [Full Text]

J. Vadnais, G. Nault, Z. Daher, M. Amraei, Y. Dodier, I. R. Nabi, and J. Noel
Autocrine Activation of the Hepatocyte Growth Factor Receptor/Met Tyrosine Kinase Induces Tumor Cell Motility by Regulating Pseudopodial Protrusion
J. Biol. Chem., December 6, 2002; 277(50): 48342 - 48350.
[Abstract] [Full Text] [PDF]

C. P. Webb, C. D. Hose, S. Koochekpour, M. Jeffers, M. Oskarsson, E. Sausville, A. Monks, and G. F. Vande Woude
The Geldanamycins Are Potent Inhibitors of the Hepatocyte Growth Factor/Scatter Factor-Met-Urokinase Plasminogen Activator-Plasmin Proteolytic Network
Cancer Res., January 1, 2000; 60(2): 342 - 349.
[Abstract] [Full Text]

D. Tulasne, R. Paumelle, K. M. Weidner, B. Vandenbunder, and V. Fafeur
The Multisubstrate Docking Site of the MET Receptor Is Dispensable for MET-mediated RAS Signaling and Cell Scattering
Mol. Biol. Cell, March 1, 1999; 10(3): 551 - 565.
[Abstract] [Full Text]

C. P. Webb, L. Van Aelst, M. H. Wigler, and G. F. Vande Woude
Signaling pathways in Ras-mediated tumorigenicity and metastasis
PNAS, July 21, 1998; 95(15): 8773 - 8778.
[Abstract] [Full Text] [PDF]

P. L. Hordijk, J. P. ten Klooster, R. A. van der Kammen, F. Michiels, L. C. Oomen, and J. G. Collard
Inhibition of Invasion of Epithelial Cells by Tiam1-Rac Signaling
Science, November 21, 1997; 278(5342): 1464 - 1466.
[Abstract] [Full Text]

M. Jeffers, L. Schmidt, N. Nakaigawa, C. P. Webb, G. Weirich, T. Kishida, B. Zbar, and G. F. Vande Woude
Activating mutations for the Met tyrosine kinase receptor in human�cancer
PNAS, October 14, 1997; 94(21): 11445 - 11450.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Webb, C. P.

Articles by Warn, R. M.

Search for Related Content

PubMed

PubMed Citation

Articles by Webb, C. P.

Articles by Warn, R. M.

				J. Vadnais, G. Nault, Z. Daher, M. Amraei, Y. Dodier, I. R. Nabi, and J. Noel Autocrine Activation of the Hepatocyte Growth Factor Receptor/Met Tyrosine Kinase Induces Tumor Cell Motility by Regulating Pseudopodial Protrusion J. Biol. Chem., December 6, 2002; 277(50): 48342 - 48350. [Abstract] [Full Text] [PDF]

				C. P. Webb, C. D. Hose, S. Koochekpour, M. Jeffers, M. Oskarsson, E. Sausville, A. Monks, and G. F. Vande Woude The Geldanamycins Are Potent Inhibitors of the Hepatocyte Growth Factor/Scatter Factor-Met-Urokinase Plasminogen Activator-Plasmin Proteolytic Network Cancer Res., January 1, 2000; 60(2): 342 - 349. [Abstract] [Full Text]

				D. Tulasne, R. Paumelle, K. M. Weidner, B. Vandenbunder, and V. Fafeur The Multisubstrate Docking Site of the MET Receptor Is Dispensable for MET-mediated RAS Signaling and Cell Scattering Mol. Biol. Cell, March 1, 1999; 10(3): 551 - 565. [Abstract] [Full Text]

				C. P. Webb, L. Van Aelst, M. H. Wigler, and G. F. Vande Woude Signaling pathways in Ras-mediated tumorigenicity and metastasis PNAS, July 21, 1998; 95(15): 8773 - 8778. [Abstract] [Full Text] [PDF]

				P. L. Hordijk, J. P. ten Klooster, R. A. van der Kammen, F. Michiels, L. C. Oomen, and J. G. Collard Inhibition of Invasion of Epithelial Cells by Tiam1-Rac Signaling Science, November 21, 1997; 278(5342): 1464 - 1466. [Abstract] [Full Text]

				M. Jeffers, L. Schmidt, N. Nakaigawa, C. P. Webb, G. Weirich, T. Kishida, B. Zbar, and G. F. Vande Woude Activating mutations for the Met tyrosine kinase receptor in human�cancer PNAS, October 14, 1997; 94(21): 11445 - 11450. [Abstract] [Full Text] [PDF]